Search Results - "Ellis, Georgiana"

Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer by ELLIS, Georgiana K, BONE, Henry G, CHLEBOWSKI, Rowan, PAUL, Devchand, SPADAFORA, Silvana, SMITH, Judy, FAN, Michelle, JUN, Susie

“…Adjuvant aromatase inhibitor therapy is well established in postmenopausal women with hormone receptor-positive breast cancer, but such therapy is complicated…”
Get full text

Quantitative Fluoroestradiol Positron Emission Tomography Imaging Predicts Response to Endocrine Treatment in Breast Cancer by LINDEN, Hannah M, STEKHOVA, Svetlana A, KROHN, Kenneth A, MANKOFF, David A, LINK, Jeanne M, GRALOW, Julie R, LIVINGSTON, Robert B, ELLIS, Georgiana K, PETRA, Philip H, PETERSON, Lanell M, SCHUBERT, Erin K, DUNNWALD, Lisa K

“…In breast cancer, [(18)F]fluoroestradiol (FES) positron emission tomography (PET) correlates with estrogen receptors (ER) expression and predicts response to…”
Get full text

PET Tumor Metabolism in Locally Advanced Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: Value of Static versus Kinetic Measures of Fluorodeoxyglucose Uptake by DUNNWALD, Lisa K, DOOT, Robert K, MUZI, Mark, MANKOFF, David A, SPECHT, Jennifer M, GRALOW, Julie R, ELLIS, Georgiana K, LIVINGSTON, Robert B, LINDEN, Hannah M, GADI, Vijayakrishna K, KURLAND, Brenda F, SCHUBERT, Erin K

“…Changes in tumor metabolism from positron emission tomography (PET) in locally advanced breast cancer (LABC) patients treated with neoadjuvant chemotherapy…”
Get full text

Fluoroestradiol Positron Emission Tomography Reveals Differences in Pharmacodynamics of Aromatase Inhibitors, Tamoxifen, and Fulvestrant in Patients with Metastatic Breast Cancer by LINDEN, Hannah M, KURLAND, Brenda F, LINK, Jeanne M, KROHN, Kenneth A, MANKOFF, David A, PETERSON, Lanell M, SCHUBERT, Erin K, GRALOW, Julie R, SPECHT, Jennifer M, ELLIS, Georgiana K, LAWTON, Thomas J, LIVINGSTON, Robert B, PETRA, Philip H

“…To determine, by molecular imaging, how in vivo pharmacodynamics of estrogen-estrogen receptor (ER) binding differ between types of standard endocrine therapy…”
Get full text

Tumor Metabolism and Blood Flow Changes by Positron Emission Tomography: Relation to Survival in Patients Treated With Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer by DUNNWALD, Lisa K, GRALOW, Julie R, SCHUBERT, Erin K, MANKOFF, David A, ELLIS, Georgiana K, LIVINGSTON, Robert B, LINDEN, Hannah M, SPECHT, Jennifer M, DOOT, Robert K, LAWTON, Thomas J, BARLOW, William E, KURLAND, Brenda F

“…Patients with locally advanced breast carcinoma (LABC) receive preoperative chemotherapy to provide early systemic treatment and assess in vivo tumor response…”
Get full text

Effect of denosumab on bone mineral density in women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: subgroup analyses of a phase 3 study by Ellis, Georgiana K, Bone, Henry G, Chlebowski, Rowan, Paul, Devchand, Spadafora, Silvana, Fan, Michelle, Kim, Dennis

“…Denosumab increased lumbar spine bone mineral density (BMD) versus placebo in a 2-year, randomized, placebo-controlled, phase 3 study of patients with…”
Get full text

Phase III Comparison of Standard Doxorubicin and Cyclophosphamide Versus Weekly Doxorubicin and Daily Oral Cyclophosphamide Plus Granulocyte Colony-Stimulating Factor As Neoadjuvant Therapy for Inflammatory and Locally Advanced Breast Cancer: SWOG 0012 by ELLIS, Georgiana K, BARLOW, William E, GRALOW, Julie R, HORTOBAGYI, Gabriel N, RUSSELL, Christy A, ROYCE, Melanie E, PEREZ, Edith A, LEW, Danika, LIVINGSTON, Robert B

“…Patients with inflammatory breast cancer (IBC) or locally advanced breast cancer (LABC) were randomly assigned to 21-day doxorubicin and cyclophosphamide…”
Get full text

HER-2 Testing in Breast Cancer Using Parallel Tissue-Based Methods by Yaziji, Hadi, Goldstein, Lynn C, Barry, Todd S, Werling, Robert, Hwang, Harry, Ellis, Georgiana K, Gralow, Julie R, Livingston, Robert B, Gown, Allen M

“…CONTEXT Testing for HER-2 oncogene in breast cancer has increased because of its role as a prognostic and predictive factor. Some advocate gene testing by…”
Get full text

A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer by Symonds, Lynn, Jenkins, Isaac, Linden, Hannah M, Kurland, Brenda, Gralow, Julie R, Gadi, Vijayakrishna (V.K.), Ellis, Georgiana K, Wu, Qian, Rodler, Eve, Chalasani, Pavani, Chai, Xiaoyu, Riedel, Jinny, SCCA Network Investigators, Stopeck, Alison, Brown-Glaberman, Ursa, Specht, Jennifer M

“…Neoadjuvant chemotherapy is standard treatment for locally advanced breast cancer (LABC) or inflammatory breast cancer (IBC). We hypothesized that adding…”
Get full text

Serial 2-[18F] fluoro -2 -deoxy -D -glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP) by SPECHT, Jennifer M, TAM, Stephen L, KURLAND, Brenda F, GRALOW, Julie R, LIVINGSTON, Robert B, LINDEN, Hannah M, ELLIS, Georgiana K, SCHUBERT, Erin K, DUNNWALD, Lisa K, MANKOFF, David A

“…The response of bone-dominant (BD) breast cancer to therapy is difficult to assess by conventional imaging. Our preliminary studies have shown that…”
Get full text

The science and practice of bone health in oncology: managing bone loss and metastasis in patients with solid tumors by Lipton, Allan, Uzzo, Robert, Amato, Robert J, Ellis, Georgiana K, Hakimian, Behrooz, Roodman, G David, Smith, Matthew R

“…Cancer and its treatment can compromise bone health, leading to fracture, pain, loss of mobility, and hypercalcemia of malignancy. Bone metastasis occurs…”
Get more information

Changes in Blood Flow and Metabolism in Locally Advanced Breast Cancer Treated with Neoadjuvant Chemotherapy by Mankoff, David A, Dunnwald, Lisa K, Gralow, Julie R, Ellis, Georgiana K, Schubert, Erin K, Tseng, Jeffrey, Lawton, Thomas J, Linden, Hannah M, Livingston, Robert B

“…Locally advanced breast cancer (LABC) is commonly treated with neoadjuvant chemotherapy followed by definitive surgery. The factors influencing the response of…”
Get full text

Adjuvant Metronomic CMF in a Contemporary Breast Cancer Cohort: What's Old Is New by Cho, Eunpi, Schwemm, Ann K, Rubinstein, Lena M, Stevenson, Philip A, Gooley, Ted A, Ellis, Georgiana K, Specht, Jennifer M, Livingston, Robert B, Linden, Hannah M, Gadi, Vijayakrishna K

“…Micro-Abstract We reviewed our institutional experience with the adjuvant regimen of oral cyclophosphamide, with weekly intravenous methotrexate and…”
Get full text

Blood Flow and Metabolism in Locally Advanced Breast Cancer: Relationship to Response to Therapy by Mankoff, David A, Dunnwald, Lisa K, Gralow, Julie R, Ellis, Georgiana K, Charlop, Aaron, Lawton, Thomas J, Schubert, Erin K, Tseng, Jeffrey, Livingston, Robert B

“…Locally advanced breast cancer (LABC) is commonly treated with neoadjuvant chemotherapy followed by definitive surgery. The factors influencing the response of…”
Get full text

Treatment-Induced Bone Loss and Fractures in Cancer Patients Undergoing Hormone Ablation Therapy: Efficacy and Safety of Denosumab by Lipton, Allan, Smith, Matthew R., Ellis, Georgiana K., Goessl, Carsten

“…Hormone ablation therapy (HALT) for breast or prostate cancer accelerates the development of osteoporosis in both men and women by causing estrogen deficiency,…”
Get full text

Potential of chemotherapy-herb interactions in adult cancer patients by McCune, Jeannine S, Hatfield, Amy J, Blackburn, Anne A R, Leith, Patricia O, Livingston, Robert B, Ellis, Georgiana K

“…The purpose of this study was to examine the specific herbs or vitamins (HV) used by patients receiving chemotherapy. Specifically, the following aspects were…”
Get full text

Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC) by Bellon, Jennifer R, Livingston, Robert B, Eubank, William B, Gralow, Julie R, Ellis, Georgiana K, Dunnwald, Lisa K, Mankoff, David A

“…The presence of internal mammary (IM) lymph node metastases in breast cancer predicts outcome and may alter treatment. Standard imaging has limited usefulness…”
Get full text

Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012) by Slovak, Marilyn L., Bedell, Victoria, Lew, Danika, Albain, Kathy S., Ellis, Georgiana K., Livingston, Robert B., Martino, Silvana, Perez, Edith A., Hortobagyi, Gabriel N., Sher, Dorie, Stock, Wendy

“…A serious complication associated with breast cancer treatment is the increased risk for development of therapy-related myeloid neoplasms (t-MN). To determine…”
Get full text

Dose-Dense Anthracycline-Based Chemotherapy for Node-Positive Breast Cancer by ELLIS, Georgiana K, LIVINGSTON, Robert B, GRALOW, Julie R, GREEN, Stephanie J, THOMPSON, Tove

“…Theoretical considerations and clinical experience suggest that dose-dense chemotherapy may be superior to other approaches using the same drugs. We studied a…”
Get full text

Residual tumor uptake of [99mTc]‐sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival by Dunnwald, Lisa K., Gralow, Julie R., Ellis, Georgiana K., Livingston, Robert B., Linden, Hannah M., Lawton, Thomas J., Barlow, William E., Schubert, Erin K., Mankoff, David A.

“…BACKGROUND Studies utilizing serial [99mTc]‐sestamibi (MIBI) scintimammography have reported accurate prediction of tumor response in patients with locally…”
Get full text